CalciMedica, Inc.

NasdaqCM:CALC Stock Report

Market Cap: US$9.8m

CalciMedica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CALC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Sep 25BuyUS$7,675Eric RobertsIndividual2,500US$3.07
15 Sep 25BuyUS$9,105Eric RobertsIndividual3,400US$2.68
12 Sep 25BuyUS$15,600Eric RobertsIndividual5,000US$3.12
09 Sep 25BuyUS$7,378Eric RobertsIndividual2,343US$3.15
29 Aug 25BuyUS$28,532Eric RobertsIndividual10,000US$2.86
21 Aug 25BuyUS$9,797Eric RobertsIndividual3,508US$2.79
20 Aug 25BuyUS$8,230Eric RobertsIndividual3,000US$2.79
19 Aug 25BuyUS$26,962Sudarshan HebbarIndividual9,563US$2.82
15 Aug 25BuyUS$16,361Sudarshan HebbarIndividual5,976US$2.79
15 Aug 25BuyUS$14,709Eric RobertsIndividual5,076US$2.90
28 Jul 25BuyUS$3,960Kenneth StaudermanIndividual1,000US$3.96
25 Jul 25SellUS$3,650Kenneth StaudermanIndividual1,000US$3.65
22 Jul 25BuyUS$5,663Eric RobertsIndividual1,500US$3.78
21 Jul 25BuyUS$3,400A. LehenyIndividual1,000US$3.40
21 Jul 25BuyUS$5,055Eric RobertsIndividual1,500US$3.37
18 Jul 25BuyUS$5,760Eric RobertsIndividual2,000US$2.88
18 Jul 25BuyUS$12,915Robert WilsonIndividual4,500US$2.87
14 Jul 25BuyUS$6,175A. LehenyIndividual2,500US$2.47
14 Jul 25BuyUS$15,810Eric RobertsIndividual6,500US$2.43
09 Jul 25BuyUS$8,024Eric RobertsIndividual5,000US$1.60
01 Jul 25BuyUS$1,850Kenneth StaudermanIndividual1,000US$1.85
26 Jun 25BuyUS$3,005Stephen BardinIndividual2,000US$1.50
26 Jun 25BuyUS$6,483Eric RobertsIndividual4,500US$1.44
11 Jun 25BuyUS$9,250Eric RobertsIndividual5,000US$1.85
06 Jun 25BuyUS$17,545Eric RobertsIndividual10,100US$1.78
30 May 25BuyUS$1,690Stephen BardinIndividual1,000US$1.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CALC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,750,31719.1%
Institutions3,153,95621.9%
General Public3,775,50726.2%
VC/PE Firms4,729,65132.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.8%.

Top Shareholders

Top 25 shareholders own 71.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.7%
Sanderling Ventures
2,407,172US$1.6m0%100.0%
11%
Alafi Capital Company LLC
1,583,153US$1.1m0%100.0%
7.88%
Jorey Chernett
1,134,847US$773.7k0%no data
5.13%
Valence Life Sciences
739,326US$504.1k0%no data
4.75%
Soleus Capital Management, L.P.
683,904US$466.3k0%0.01%
4.6%
Bering Capital
663,246US$452.2k0%no data
3.62%
Aisling Capital Management LP
521,114US$355.3k0%0.06%
3.25%
Laurence Lytton
468,943US$319.7k0%no data
2.93%
Robert Wilson
422,029US$287.7k0%no data
2.83%
The Vanguard Group, Inc.
407,801US$278.0k8.28%no data
2.25%
Eric Roberts
324,411US$221.2k0%no data
0.94%
A. Leheny
135,426US$92.3k0%no data
0.69%
Geode Capital Management, LLC
99,787US$68.0k0.95%no data
0.63%
Frederic Guerard
90,727US$61.9k0%no data
0.61%
Renaissance Technologies LLC
88,300US$60.2k26.1%no data
0.53%
Boothbay Fund Management, LLC
76,855US$52.4k0%no data
0.44%
Envestnet Asset Management, Inc.
63,186US$43.1k-17.6%no data
0.43%
Meritage Portfolio Management, Inc.
61,539US$42.0k0%no data
0.43%
Sudarshan Hebbar
61,539US$42.0k0%no data
0.37%
Stonehage Fleming (Uk) Limited
53,703US$36.6k0%no data
0.35%
Sheets Smith Investment Management, LLC
51,100US$34.8k0%0.02%
0.35%
CIBC World Markets Corp.
49,894US$34.0k0%no data
0.32%
PVG Asset Management Corp
45,830US$31.2k0%0.04%
0.31%
Fred Middleton
44,690US$30.5k0%no data
0.3%
Stephen Bardin
43,000US$29.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/05 11:18
End of Day Share Price 2026/03/05 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CalciMedica, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph PantginisH.C. Wainwright & Co.
Catherine NovackJonesTrading Institutional Services, LLC
Dev PrasadLucid Capital Markets